{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:12:29Z","timestamp":1784261549075,"version":"3.55.0"},"reference-count":151,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.metabol.2015.08.018","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T16:45:32Z","timestamp":1441125932000},"page":"1026-1037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Genetics of nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"65","author":[{"given":"Paola","family":"Dongiovanni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8909-0345","authenticated-orcid":false,"given":"Luca","family":"Valenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2015.08.018_bb0005","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2015.08.018_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/j.gastro.2005.11.017","article-title":"From fat to inflammation","volume":"130","author":"Day","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/gast.2002.34168","article-title":"Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma","volume":"123","author":"Bugianesi","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0020","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0025","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.2174\/13816128113199990381","article-title":"Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment","volume":"19","author":"Dongiovanni","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.metabol.2015.08.018_bb0030","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.metabol.2015.08.018_bb0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0040","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0045","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2015.08.018_bb0050","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","article-title":"Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms","volume":"48","author":"Bugianesi","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2015.08.018_bb0055","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2008.01.075","article-title":"Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects","volume":"134","author":"Korenblat","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0060","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2015.08.018_bb0065","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/hep.27839","article-title":"Hepatic lipid droplet biology: getting to the root of fatty liver","volume":"62","author":"Mashek","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0070","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\"?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0075","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00281-009-0152-9","article-title":"The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?","volume":"31","author":"Valenti","year":"2009","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0085","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0090","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep.23046","article-title":"Adipokines in liver diseases","volume":"50","author":"Marra","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0095","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0100","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1053\/j.gastro.2009.01.050","article-title":"Heritability of nonalcoholic fatty liver disease","volume":"136","author":"Schwimmer","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0105","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.22726","article-title":"Ethnic differences in hepatic steatosis: an insulin resistance paradox?","volume":"49","author":"Guerrero","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0110","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1111\/j.1572-0241.2001.04667.x","article-title":"Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease","volume":"96","author":"Willner","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0115","doi-asserted-by":"crossref","first-page":"E1140","DOI":"10.1152\/ajpendo.00620.2009","article-title":"Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats","volume":"298","author":"Minamiyama","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.08.018_bb0120","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1478-3231.2006.01329.x","article-title":"Effects of iron overload in a rat nutritional model of non-alcoholic fatty liver disease","volume":"26","author":"Kirsch","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2015.08.018_bb0125","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0016-5085(03)00907-7","article-title":"Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis","volume":"125","author":"Feldstein","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jhep.2008.12.025","article-title":"Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins","volume":"50","author":"Makkonen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0135","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1053\/j.gastro.2004.07.019","article-title":"Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses","volume":"127","author":"Takehara","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0755","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1053\/j.gastro.2010.06.009","article-title":"Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins","volume":"139","author":"Loomba","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0145","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2015.08.018_bb0150","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.3748\/wjg.v19.i41.6969","article-title":"PNPLA3 I148M polymorphism and progressive liver disease","volume":"19","author":"Dongiovanni","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0155","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2015.08.018_bb0160","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hep.27490","article-title":"Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease","volume":"61","author":"Dongiovanni","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0165","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1073\/pnas.1003585107","article-title":"A feed-forward loop amplifies nutritional regulation of PNPLA3","volume":"107","author":"Huang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2015.08.018_bb0170","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","article-title":"A sequence variation (I148M) in PNPlA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis","volume":"285","author":"He","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2015.08.018_bb0175","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.bbalip.2013.12.006","article-title":"Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function","volume":"1481","author":"Pingitore","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2015.08.018_bb0180","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1093\/hmg\/ddu121","article-title":"PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells","volume":"23","author":"Pirazzi","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2015.08.018_bb0185","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1194\/jlr.M046607","article-title":"PNPLA3 mediates hepatocyte triacylglycerol remodeling","volume":"55","author":"Ruhanen","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2015.08.018_bb0190","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","article-title":"A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis","volume":"285","author":"He","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2015.08.018_bb0195","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.jhep.2012.07.030","article-title":"Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro","volume":"57","author":"Pirazzi","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0200","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0205","first-page":"47","article-title":"TNFalpha promoter polymorphisms","volume":"98","author":"Fargion","year":"2004","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.metabol.2015.08.018_bb0210","doi-asserted-by":"crossref","first-page":"E821","DOI":"10.1210\/jc.2014-4464","article-title":"Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant","volume":"100","author":"Mancina","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.08.018_bb0215","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s00125-009-1285-z","article-title":"A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans","volume":"52","author":"Kotronen","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2015.08.018_bb0760","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1093\/hmg\/ddp424","article-title":"Genetic evidence for a role of adiponutrin in the metabolism of apolipoprotein B-containing lipoproteins","volume":"18","author":"Kollerits","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2015.08.018_bb0225","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.2337\/db09-0279","article-title":"Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene","volume":"58","author":"Kantartzis","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2015.08.018_bb0230","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/hep.23759","article-title":"The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease","volume":"52","author":"Rotman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0235","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hep.23768","article-title":"PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease","volume":"52","author":"Speliotes","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0765","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/hep.23622","article-title":"Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"51","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0245","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease","volume":"53","author":"Sookoian","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0250","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2010.02.034","article-title":"The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life","volume":"53","author":"Romeo","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0255","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/hep.23832","article-title":"A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents","volume":"52","author":"Santoro","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0770","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep.23823","article-title":"I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease","volume":"52","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0265","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/ijpo.234","article-title":"Associations of I148M variant in PNPLA3 gene with plasma ALT levels during 2-year follow-up in normal weight and overweight children: the PANIC Study","volume":"10","author":"Viitasalo","year":"2014","journal-title":"Pediatr Obes"},{"key":"10.1016\/j.metabol.2015.08.018_bb0270","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ijo.2009.216","article-title":"Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent","volume":"34","author":"Romeo","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2015.08.018_bb0275","doi-asserted-by":"crossref","first-page":"e27933","DOI":"10.1371\/journal.pone.0027933","article-title":"The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat","volume":"6","author":"Miraglia Del Giudice","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2015.08.018_bb0280","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/ijo.2012.65","article-title":"PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: the NHLBI Family Heart Study","volume":"37","author":"Graff","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2015.08.018_bb0285","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.24123","article-title":"Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C","volume":"53","author":"Valenti","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0290","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.26445","article-title":"PNPLA3 I148M affects liver steatosis in patients with chronic hepatitis B","volume":"58","author":"Vigano","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0295","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.3748\/wjg.v18.i22.2813","article-title":"PNPLA3 I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis","volume":"18","author":"Valenti","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0300","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2015.01.034","article-title":"Hepatic steatosis in Wilson disease \u2014 role of copper and PNPLA3 mutations","volume":"63","author":"Stattermayer","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0305","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng.488","article-title":"Variant in PNPLA3 is associated with alcoholic liver disease","volume":"42","author":"Tian","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2015.08.018_bb0310","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3945\/ajcn.2010.30185","article-title":"Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption","volume":"92","author":"Davis","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2015.08.018_bb0315","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12263-014-0392-8","article-title":"Influence of dietary pattern, physical activity, and I148M PNPLA3 on steatosis severity in at-risk adolescents","volume":"9","author":"Nobili","year":"2014","journal-title":"Genes Nutr"},{"key":"10.1016\/j.metabol.2015.08.018_bb0320","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3945\/ajcn.112.038695","article-title":"Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans","volume":"96","author":"Sevastianova","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2015.08.018_bb0325","doi-asserted-by":"crossref","first-page":"e37827","DOI":"10.1371\/journal.pone.0037827","article-title":"Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6\/omega3 PUFA intake","volume":"7","author":"Santoro","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2015.08.018_bb0330","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1089\/jmf.2013.0043","article-title":"The I148M variant of PNPLA3 reduces the response to docosahexaenoic acid in children with non-alcoholic fatty liver disease","volume":"16","author":"Nobili","year":"2013","journal-title":"J Med Food"},{"key":"10.1016\/j.metabol.2015.08.018_bb0775","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.24123","article-title":"Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C","volume":"53","author":"Valenti","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0340","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1365-2036.2012.05109.x","article-title":"Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin","volume":"35","author":"Valenti","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.metabol.2015.08.018_bb0345","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jhep.2011.04.032","article-title":"Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C","volume":"55","author":"Valenti","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0350","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/hep.25518","article-title":"PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis","volume":"55","author":"Trepo","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0355","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.dld.2012.12.006","article-title":"PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease","volume":"45","author":"Valenti","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.metabol.2015.08.018_bb0360","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/hep.26767","article-title":"Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data","volume":"59","author":"Trepo","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0365","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/hep.23622","article-title":"Homozygosity for the PNPLA3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"51","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0370","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.25634","article-title":"I148M PNPLA3 variant and progressive liver disease: a new paradigm in hepatology","volume":"56","author":"Valenti","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0375","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep.23823","article-title":"I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease","volume":"52","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0380","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3945\/jn.115.210633","article-title":"PNPLA3 I148M variant influences circulating retinol in adults with nonalcoholic fatty liver disease or obesity","volume":"145","author":"Mondul","year":"2015","journal-title":"J Nutr"},{"key":"10.1016\/j.metabol.2015.08.018_bb0385","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2337\/db13-0774","article-title":"Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity","volume":"63","author":"Hyysalo","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2015.08.018_bb0390","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1194\/jlr.P900013-JLR200","article-title":"A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity","volume":"50","author":"Sookoian","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2015.08.018_bb0395","doi-asserted-by":"crossref","first-page":"S516","DOI":"10.1016\/S0168-8278(13)61276-3","article-title":"Carriage of PNPLA3 I148M is associated with increased risk of nonalcoholic fatty liver disease-associated hepatocellular carcinoma","volume":"58","author":"Liu","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0400","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jhep.2013.12.009","article-title":"A population-based study on the prevalence of NASH using scores validated against liver histology","volume":"60","author":"Hyysalo","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0405","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/MPG.0000000000000279","article-title":"A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease","volume":"58","author":"Nobili","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.metabol.2015.08.018_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2015.07.036","article-title":"Treating liver fat and serum triglyceride levels in NAFLD, effects of PNPLA3 and TM6SF2 genotypes: results from the WELCOME trial","author":"Scorletti","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0415","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2015.05.006","article-title":"Statin use and nonalcoholic steatohepatitis in at risk individuals","volume":"63","author":"Dongiovanni","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0420","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3945\/ajcn.111.012369","article-title":"Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans","volume":"94","author":"Sevastianova","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2015.08.018_bb0425","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/01.ATV.0000178169.95781.49","article-title":"Heme oxygenase and atherosclerosis","volume":"25","author":"Morita","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0430","doi-asserted-by":"crossref","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","author":"Speliotes","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.metabol.2015.08.018_bb0435","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1315496","article-title":"Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes","volume":"370","author":"Albert","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2015.08.018_bb0440","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ng1951","article-title":"The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy","volume":"39","author":"Fischer","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2015.08.018_bb0445","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1007487","article-title":"Perilipin deficiency and autosomal dominant partial lipodystrophy","volume":"364","author":"Gandotra","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2015.08.018_bb0450","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2015.08.018_bb0455","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng.2926","article-title":"Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk","volume":"46","author":"Holmen","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2015.08.018_bb0460","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2015.08.018_bb0465","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2008.01.016","article-title":"Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease","volume":"48","author":"Chalasani","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0470","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/hep.27811","article-title":"Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients","volume":"62","author":"Milano","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0780","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/hep.24072","article-title":"Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance","volume":"53","author":"Kozlitina","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0480","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.2337\/dc05-1592","article-title":"Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study","volume":"29","author":"Acton","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.08.018_bb0485","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jhep.2011.03.035","article-title":"The APOC3 T-455C and C-482 T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver","volume":"55","author":"Valenti","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0490","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/ATVBAHA.112.301101","article-title":"A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia","volume":"33","author":"Cefalu","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0495","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jhep.2014.05.023","article-title":"Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia","volume":"61","author":"Di Filippo","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0500","doi-asserted-by":"crossref","first-page":"e87523","DOI":"10.1371\/journal.pone.0087523","article-title":"Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease","volume":"9","author":"Petta","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2015.08.018_bb0505","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1093\/hmg\/ddp357","article-title":"The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver","volume":"18","author":"Beer","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2015.08.018_bb0510","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ijo.2012.181","article-title":"Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects","volume":"37","author":"Rametta","year":"2013","journal-title":"Int J Obes"},{"key":"10.1016\/j.metabol.2015.08.018_bb0515","doi-asserted-by":"crossref","first-page":"E1126","DOI":"10.1210\/jc.2010-2017","article-title":"Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans","volume":"96","author":"Peter","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2015.08.018_bb0520","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1038\/ncomms6190","article-title":"Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors","volume":"5","author":"Haeusler","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2015.08.018_bb0525","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/hep.24806","article-title":"Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents","volume":"55","author":"Santoro","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0530","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.25617","article-title":"Unraveling the genetics of fatty liver in obese children: additive effect of P446L GCKR and I148M PNPLA3 polymorphisms","volume":"55","author":"Valenti","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0535","doi-asserted-by":"crossref","first-page":"8625","DOI":"10.1073\/pnas.95.15.8625","article-title":"A family of fatty acid transporters conserved from mycobacterium to man","volume":"95","author":"Hirsch","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2015.08.018_bb0540","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1053\/j.gastro.2006.02.012","article-title":"Mice deleted for fatty acid transport protein 5 have defective bile acid conjugation and are protected from obesity","volume":"130","author":"Hubbard","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0545","doi-asserted-by":"crossref","first-page":"22186","DOI":"10.1074\/jbc.M803510200","article-title":"Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia","volume":"283","author":"Doege","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2015.08.018_bb0550","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1055\/s-0030-1267186","article-title":"A promoter polymorphism in the liver-specific fatty acid transport protein 5 is associated with features of the metabolic syndrome and steatosis","volume":"42","author":"Auinger","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.metabol.2015.08.018_bb0555","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.2337\/dc05-1592","article-title":"Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study","volume":"29","author":"Acton","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.08.018_bb0560","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-230X-10-102","article-title":"Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study","volume":"10","author":"Dongiovanni","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0565","doi-asserted-by":"crossref","first-page":"452061","DOI":"10.1155\/2013\/452061","article-title":"Peroxisome proliferator-activated receptor genetic polymorphisms and nonalcoholic Fatty liver disease: any role in disease susceptibility?","volume":"2013","author":"Dongiovanni","year":"2013","journal-title":"PPAR Res"},{"key":"10.1016\/j.metabol.2015.08.018_bb0570","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2015.08.018_bb0575","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.2337\/dc06-0513","article-title":"Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals","volume":"29","author":"Tonjes","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2015.08.018_bb0580","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","article-title":"Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase","volume":"15","author":"Kumari","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2015.08.018_bb0585","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1126\/science.1161524","article-title":"A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection","volume":"322","author":"Pollin","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.metabol.2015.08.018_bb0590","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/MPG.0b013e3182442a55","article-title":"LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease","volume":"54","author":"Valenti","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.metabol.2015.08.018_bb0595","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(99)80033-6","article-title":"Mitochondrial abnormalities in non-alcoholic steatohepatitis","volume":"31","author":"Caldwell","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0600","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cmet.2014.07.004","article-title":"Fatty acid flippase activity of UCP2 is essential for its proton transport in mitochondria","volume":"20","author":"Berardi","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2015.08.018_bb0605","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/liv.12707","article-title":"The UCP2\u2013866G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis","volume":"35","author":"Fares","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2015.08.018_bb0610","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1053\/j.gastro.2009.11.013","article-title":"HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"138","author":"Valenti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0615","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1006\/bbrc.1996.1394","article-title":"Structural dimorphism in the mitochondrial targeting sequence in the human manganese superoxide dismutase gene. A predictive evidence for conformational change to influence mitochondrial transport and a study of allelic association in Parkinson's disease","volume":"226","author":"Shimoda-Matsubayashi","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2015.08.018_bb0620","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00008571-200303000-00004","article-title":"The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria","volume":"13","author":"Sutton","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.metabol.2015.08.018_bb0625","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2011.05.029","article-title":"The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies","volume":"56","author":"Al-Serri","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0630","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jhep.2004.01.028","article-title":"Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis","volume":"40","author":"Namikawa","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0635","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1053\/j.gastro.2009.11.013","article-title":"HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"138","author":"Valenti","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0640","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2010.05.023","article-title":"Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease","volume":"53","author":"Valenti","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0645","doi-asserted-by":"crossref","first-page":"e48804","DOI":"10.1371\/journal.pone.0048804","article-title":"The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease","volume":"7","author":"Valenti","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2015.08.018_bb0650","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00125-006-0353-x","article-title":"Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects","volume":"49","author":"Grarup","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2015.08.018_bb0655","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/gut.2009.190801","article-title":"Genetic variants regulating Insulin Receptor signaling are associated with the severity of liver damage in patients with nonalcoholic fatty liver disease","volume":"59","author":"Dongiovanni","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2015.08.018_bb0660","first-page":"265A","article-title":"Genome-wide association analysis confirms importance of PNPLA3 and identifies novel variants associated with histologically progressive steatohepatitis in NAFLD","volume":"56","author":"Anstee","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0665","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1507\/endocrj.EJ14-0052","article-title":"Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits","volume":"61","author":"Kitamoto","year":"2014","journal-title":"Endocr J"},{"key":"10.1016\/j.metabol.2015.08.018_bb0670","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/JME-13-0243","article-title":"TRIB1 downregulates hepatic lipogenesis and glycogenesis via multiple molecular interactions","volume":"52","author":"Ishizuka","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0675","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1194\/jlr.M057802","article-title":"Sin3A-associated protein, 18kDa, a novel binding partner of TRIB1, regulates MTTP expression","volume":"56","author":"Makishima","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2015.08.018_bb0680","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1053\/gast.2002.31065","article-title":"Tumor necrosis factor alpha promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease","volume":"122","author":"Valenti","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0685","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1097\/01.alc.0000187595.19324.ca","article-title":"238G>A polymorphism of tumor necrosis factor alpha gene (TNFA) is associated with alcoholic liver cirrhosis in alcoholic Spanish men","volume":"29","author":"Pastor","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.metabol.2015.08.018_bb0690","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.1440-1746.2003.02984.x","article-title":"Steatosis in chronic hepatitis C: association with increased messenger RNA expression of collagen I, tumor necrosis factor-alpha and cytochrome P450 2E1","volume":"18","author":"Gochee","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0695","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jhep.2012.01.007","article-title":"IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease","volume":"56","author":"Petta","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0700","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1038\/ncomms7422","article-title":"Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease","volume":"6","author":"Eslam","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.metabol.2015.08.018_bb0705","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","article-title":"GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects","volume":"142","author":"Oh","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2015.08.018_bb0710","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MPG.0000000000000494","article-title":"Deciphering the role of omega3 fatty acids in nonalcoholic steatohepatitis","volume":"59","author":"Valenti","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.metabol.2015.08.018_bb0785","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MPG.0000000000000463","article-title":"Novel association between a non-synonymous variant (R270H) of the G protein-coupled receptor 120 and liver injury in obese children and adolescents","volume":"59","author":"Marzuillo","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.metabol.2015.08.018_bb0720","doi-asserted-by":"crossref","first-page":"12945","DOI":"10.3748\/wjg.v20.i36.12945","article-title":"Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors","volume":"20","author":"Dongiovanni","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2015.08.018_bb0725","doi-asserted-by":"crossref","first-page":"e7926","DOI":"10.1371\/journal.pone.0007926","article-title":"A spectrum of severe familial liver disorders associate with telomerase mutations","volume":"4","author":"Calado","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2015.08.018_bb0730","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/hep.24217","article-title":"Telomerase gene mutations are associated with cirrhosis formation","volume":"53","author":"Hartmann","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0735","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4161\/cc.28471","article-title":"Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease","volume":"13","author":"Aravinthan","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.metabol.2015.08.018_bb0740","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4161\/cc.28754","article-title":"CDKN1A: a double-edged sword in fatty liver?","volume":"13","author":"Valenti","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.metabol.2015.08.018_bb0745","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2008.04.004","article-title":"The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease","volume":"135","author":"Miele","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0750","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/hep.24793","article-title":"Glucokinase links Kruppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease","volume":"55","author":"Bechmann","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2015.08.018_bb0790","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1053\/j.gastro.2010.07.057","article-title":"Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease","volume":"139","author":"Chalasani","year":"2010","journal-title":"Gastroenterology"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515002516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049515002516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:10:24Z","timestamp":1758427824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049515002516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":151,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0026049515002516"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2015.08.018","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics of nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2015.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}